State Street
LUNG icon

State Street’s Pulmonx LUNG Stock Holding History

State Street’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$249K Sell
191,501
-617,615
-76% -$851K ﹤0.01% 3761
2026
Q1 		$1.04M Sell
809,116
-12,101
-1% -$20K ﹤0.01% 3479
2025
Q4 		$1.81M Buy
821,217
+28,813
+4% +$54.2K ﹤0.01% 3374
2025
Q3 		$1.28M Sell
792,404
-1,781
-0.2% -$3.73K ﹤0.01% 3453
2025
Q2 		$2.06M Buy
794,185
+33,439
+4% +$132K ﹤0.01% 3306
2025
Q1 		$5.12M Buy
760,746
+1,418
+0.2% +$10K ﹤0.01% 2877
2024
Q4 		$5.16M Buy
759,328
+12,300
+2% +$81K ﹤0.01% 2959
2024
Q3 		$6.19M Buy
747,028
+18,592
+3% +$135K ﹤0.01% 2859
2024
Q2 		$4.62M Sell
728,436
-246,244
-25% -$1.89M ﹤0.01% 2960
2024
Q1 		$9.04M Buy
974,680
+99,715
+11% +$1.17M ﹤0.01% 2650
2023
Q4 		$11.2M Buy
874,965
+14,542
+2% +$151K ﹤0.01% 2533
2023
Q3 		$8.89M Sell
860,423
-127,193
-13% -$1.47M ﹤0.01% 2659
2023
Q2 		$12.9M Buy
987,616
+40,639
+4% +$497K ﹤0.01% 2503
2023
Q1 		$10.6M Buy
946,977
+319,587
+51% +$3.16M ﹤0.01% 2629
2022
Q4 		$5.29M Sell
627,390
-215,461
-26% -$2.05M ﹤0.01% 3019
2022
Q3 		$14M Buy
842,851
+23,367
+3% +$430K ﹤0.01% 2491
2022
Q2 		$12.1M Buy
819,484
+11,694
+1% +$241K ﹤0.01% 2592
2022
Q1 		$20M Buy
807,790
+85,855
+12% +$2.22M ﹤0.01% 2401
2021
Q4 		$23.2M Buy
721,935
+6,016
+0.8% +$220K ﹤0.01% 2374
2021
Q3 		$25.8M Buy
715,919
+124,925
+21% +$4.92M ﹤0.01% 2297
2021
Q2 		$26.1M Buy
590,994
+252,413
+75% +$11M ﹤0.01% 2343
2021
Q1 		$15.5M Buy
338,581
+161,176
+91% +$9.24M ﹤0.01% 2509
2020
Q4 		$12.2M Buy
+177,405
New +$8.69M ﹤0.01% 2513

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ECM
ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

State Street's LUNG Position: Q2 2026 in Review

State Street reduced its Pulmonx (LUNG) stake by 76% in Q2 2026, selling an estimated $851K and leaving 191,501 shares worth $249K. The position accounts for ﹤0.01% of the portfolio, ranked #3761.

State Street first reported a position in LUNG in Q4 2020 and has held it in 23 quarters since. The position peaked at $26.1M in Q2 2021. 107 funds tracked by Wall St. Rank hold LUNG as of Q2 2026.

  • State Street held 191,501 shares of Pulmonx worth $249K as of Q2 2026.
  • State Street sold 617,615 Pulmonx shares in Q2 2026, an estimated $851K.
  • Pulmonx made up ﹤0.01% of State Street's portfolio in Q2 2026, its #3761 holding.
  • State Street first reported a position in Pulmonx in Q4 2020 and has held it in 23 quarters since.
  • State Street's Pulmonx position peaked at $26.1M in Q2 2021.
  • 107 funds tracked by Wall St. Rank held Pulmonx as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.